Skip to main content
HIVSTIsDiagnostics and screeningBehavioralBehavioral

What this study is

The goal of this clinical trial is to understand what patients and physicians think about providing medications to prevent HIV transmission to patients in a family planning clinic. These medications are known as pre-exposure prophylaxis, or PrEP. The main questions to answer are:

1. Do patients find it acceptable to be asked about, and offered, PrEP during their visit to a family planning clinic? 2. What things make it easier or harder to ask about PrEP in a family planning clinic setting? 3. What things make it easier or harder to begin PrEP in a family planning clinic setting?

Patient participants:

1. Will receive standardized counseling about PrEP. 2. Will have the opportunity to begin PrEP as part of their routine, ongoing care. 3. Will be asked to complete a survey about their experiences.

Physician participants:

1. Will receive standardized education about PrEP. 2. Will talk to patient participants about PrEP, and support patient participants who want to begin PrEP. 3. Will be asked to complete pre-and post-study surveys about their experiences. 4. May be asked to complete a post-study in-depth interview about their experiences.

What's being tested

  • Patient participant screening

    Intervention · BEHAVIORAL

    Patient participants will be provided with the standardized PrEP screening and initiation protocol.

  • Physician participant training

    Intervention · BEHAVIORAL

    Physician participants will be trained in the investigators' standardized PrEP screening and initiation protocol.

Study details

Official title
Implementing HIV Pre-Exposure Prophylaxis in a Family Planning Clinic: A Study of Feasibility and Acceptability (Aka The Pilot Fish Study)
Sponsor
Women and Infants Hospital of Rhode Island
Conditions
HIV · PrEP
Enrolling
83 people
Starts
2026-05-28
Est. completion
2026-12-31
Design
Open-label, non-randomized, parallel groups
Record
View on ClinicalTrials.gov ↗